You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gefitinib

Showing 26 - 50 of 197
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, EGFR Gene Mutation, Brain Metastases Trial in Worldwide (AZD3759, Erlotinib, Gefitinib)

Completed
  • Non-small Cell Lung Cancer
  • +2 more
  • Hefei, Anhui, China
  • +57 more
Nov 18, 2022

Lung Cancer, Nonsmall Cell Trial in Guangzhou (Gefitinib, Anlotinib Hydrochloride, Placebo)

Unknown status
  • Lung Cancer, Nonsmall Cell
  • Gefitinib
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun Yat-Sen University (CCSU)
Nov 7, 2019

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

NSCLC Trial in Worldwide (Osimertinib, Gefitinib)

Active, not recruiting
  • NSCLC
  • Bordeaux, France
  • +21 more
Mar 5, 2021

Prostate Cancer Trial in Calgary, Toronto (gefitinib)

Completed
  • Prostate Cancer
  • gefitinib
  • Calgary, Alberta, Canada
  • +1 more
Apr 2, 2020

Recurrent Uterine Corpus Carcinoma Trial in Philadelphia (Gefitinib, Laboratory Biomarker Analysis)

Completed
  • Recurrent Uterine Corpus Carcinoma
  • Gefitinib
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Metastatic NSCLC Trial in Worldwide (Ramucirumab, Placebo, Erlotinib)

Active, not recruiting
Has Results
  • Metastatic Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +109 more
Apr 18, 2022

Cancer Trial (gefitinib, Yiqi-yangyin-jiedu decoction, )

Unknown status
  • Cancer
  • gefitinib
  • +2 more
  • (no location specified)
Apr 10, 2019

Lung Tumors Trial in Worldwide (Afatinib, gefitinib)

Completed
Has Results
  • Lung Neoplasms
  • Camperdown, New South Wales, Australia
  • +62 more
Mar 26, 2020

NSCLC Trial in Worldwide (Gefitinib, Placebo, Pemetrexed)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Gefitinib
  • +3 more
  • Beijing, China
  • +60 more
Sep 24, 2020

Kidney Cancer Trial in Baltimore (gefitinib)

Completed
  • Kidney Cancer
  • gefitinib
  • Baltimore, Maryland
  • +1 more
Nov 5, 2019

Stage IV Lung Cancer Trial in France (Gefitinib, Fulvestrant, Erlotinib)

Completed
  • Stage IV Lung Cancer
  • Gefitinib
  • +2 more
  • Ambilly, France
  • +60 more
Jan 6, 2021

Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) Trial in United States (Gefitinib, AZD9291,

Completed
Has Results
  • Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)
  • Gefitinib
  • +3 more
  • Goodyear, Arizona
  • +9 more
Aug 1, 2019

Carcinoma, Non Small Cell Lung Trial in Worldwide (Gefitinib, Pemetrexed)

Completed
Has Results
  • Carcinoma, Non Small Cell Lung
  • Beijing, China
  • +24 more
Aug 28, 2019

Esophageal Cancer Trial in Baltimore (drug, procedure, radiation)

Terminated
Has Results
  • Esophageal Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 12, 2018

NSCLC, EGFR Trial in Shenzhen (Gefitinib, Vinorelbine, Carboplatin)

Unknown status
  • NSCLC
  • EGFR
  • Gefitinib
  • +2 more
  • Shenzhen, Guangdong, China
    Shenzhen People's Hospital
Aug 30, 2018

Non-squamous NSCLC Trial (Anlotinib, Gefitinib)

Unknown status
  • Non-squamous Non-small Cell Lung Cancer
  • (no location specified)
Jul 18, 2018

Non-Small-Cell Lung Trial in Suzhou (Anlotinib Hydrochloride, Gefitinib, Icotinib)

Unknown status
  • Non-Small-Cell Lung
  • Anlotinib Hydrochloride
  • +2 more
  • Suzhou, Jangsu, China
    The First Affiliated hospital of soochow university
Jan 28, 2019

Lung Adenocarcinoma, EGFR Mutation Trial in Fuzhou (gefitinib, Berberine)

Unknown status
  • Lung Adenocarcinoma
  • EGFR Mutation
  • Fuzhou, Fujian, China
    Fujian cancer hospital
Mar 31, 2018

Brain and CNS Tumors Trial in United States (gefitinib, temozolomide)

Completed
  • Brain and Central Nervous System Tumors
  • Los Angeles, California
  • +10 more
Jun 25, 2018

Brain and CNS Tumors Trial in United States (gefitinib)

Completed
  • Brain and Central Nervous System Tumors
  • gefitinib
  • Los Angeles, California
  • +11 more
Jun 22, 2018

NSCLC Trial in Seoul (gefitinib)

Unknown status
  • Non-small Cell Lung Cancer
  • gefitinib
  • Seoul, Korea, Republic of
    Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Jan 9, 2018

NSCLC Trial in Boston (Gefitinib)

Completed
  • Non-Small Cell Lung Cancer
  • Gefitinib
  • Boston, Massachusetts
  • +1 more
Jan 29, 2018

Non-squamous NSCLC Stage II, Non-squamous NSCLC Stage IIIA, Non-squamous NSCLC Stage IIIB Trial in Oldenburg (Gefitinib,

Terminated
  • Non-squamous Non-small Cell Lung Cancer Stage II
  • +4 more
  • Gefitinib
  • +3 more
  • Oldenburg, Germany
    Pius-Hospital
Jan 19, 2018

NSCLC Metastatic, EGFR Activating Mutation Trial in Chengdu (Gefitinib, gemcitabine, carboplatin)

Terminated
  • Non-small Cell Lung Cancer Metastatic
  • EGFR Activating Mutation
  • Gefitinib
  • +2 more
  • Chengdu, Sichuan, China
    China West Hospital
Nov 23, 2017